Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2004-12-09
2009-02-03
Tsang, Cecilia J (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S331000, C544S405000
Reexamination Certificate
active
07485625
ABSTRACT:
The present invention discloses novel compounds which have HCV protease inhibitory activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such compounds as well as methods of using them to treat disorders associated with the HCV protease.
REFERENCES:
patent: 7012066 (2006-03-01), Saksena et al.
patent: 2003/0216325 (2003-11-01), Saksena et al.
patent: WO 01/74768 (2001-10-01), None
patent: WO 02/08244 (2002-01-01), None
patent: WO 02/18369 (2002-03-01), None
patent: WO 02/48172 (2002-06-01), None
patent: WO 03/062228 (2003-07-01), None
patent: WO 03/062265 (2003-07-01), None
International Search Report for PCT/US2004/041579—4pgs.
Arasappan Ashok
Njoroge F. George
Velazquez Francisco
Venkatraman Srikanth
Cordero Garcia Marcela M
Farquharson-Torres Serena
Kalyanaraman Palaiyur S.
Schering Corporation
Tsang Cecilia J
LandOfFree
Inhibitors of hepatitis C virus NS3/NS4a serine protease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibitors of hepatitis C virus NS3/NS4a serine protease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibitors of hepatitis C virus NS3/NS4a serine protease will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4109619